T. cruzi: pathogenesis modulation by eicosanoids
$474,519R01FY2012AINIH
Albert Einstein College Of Medicine, Bronx NY
Investigators
Linked publications, trials & patents
Paper 30291906Paper 27640146Paper 27031954Paper 25448052Paper 25150689Paper 25102151Paper 24818665Paper 24780317Paper 24018709Paper 23467761Paper 23403991Paper 23321322Paper 23260774Paper 23201133Paper 23082110Paper 23076807Paper 23021981Paper 22820174Paper 22658486Paper 22515575Paper 22411314Paper 22309180Paper 22293860Paper 22293433Paper 22215192Paper 22201990Paper 22138018Paper 22033146Paper 22030559Paper 21914488Paper 21884894Paper 21884889Paper 21884888Paper 21884887Paper 21884885Paper 21820563Paper 21820557Paper 21797847Paper 21726660Paper 21408103Paper 21364319Paper 21347238Paper 21212020Paper 20824217Paper 20800692Paper 20726767Paper 20603604Paper 20565256Paper 20466066Paper 20452453Paper 20439965Paper 20423339Paper 20372051Paper 20195635Paper 20116865Paper 20093501Paper 19861629Paper 19753477Paper 19729072Paper 19644556Paper 19547703Paper 19478254Paper 19410685Paper 19407124Paper 19283409Paper 18951994Paper 18694966
Abstract
targets for the treatment of cardiovascular disease and our current studies are likely to provide additional targets for the treatment of this important human parasitic disease. Project Description Page 6
View original record on NIH RePORTER →